Generation Bio Co (GBIO) Stock Analysis

Generation Bio Co (GBIO) is a publicly traded company in the HEALTHCARE sector. It trades at $5.34. This page summarizes the public market data, fundamentals, and frequently asked questions for GBIO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.34

Market Sentiment

Generation Bio Co currently has a Bearish sentiment score of -0.42.

About Generation Bio Co

Generation Bio Co. is an innovative genetic drug company based in Cambridge, Massachusetts, dedicated to advancing groundbreaking gene therapies aimed at both rare and prevalent diseases. Utilizing its proprietary gene delivery platform, the company is committed to addressing critical unmet medical needs through the development of transformative treatments that promise enduring benefits. With a robust focus on research and development, Generation Bio is strategically positioned to emerge as a...

GNG Research Analysis

GNG Research scores Generation Bio Co (GBIO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GBIO.

Frequently Asked Questions

Does GBIO pay dividends?

Generation Bio Co (GBIO) does not currently pay a regular dividend.